Hyperphosphatemia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026
Hyperphosphatemia is a condition caused as a result of higher level of phosphate or phosphorous in the blood. Phosphate is a chemical present in body and contain mineral called phosphorous. Phosphorus mineral is vital for the development of teeth and bones and also convert food into energy for body. Phosphate is especially present in one's teeth, bones, inside the cells, and in very smaller amounts in the blood. Kidney functions for the management of phosphate level in the body. However, various complications/diseases results into impairment of kidney, that leads to chronically higher level of phosphate in blood. Hyperphosphatemia is extremely common in people who have chronic kidney disease more frequently in people who have end-stage kidney disease. Some other possible factors behind hyperphosphatemia includes diabetic ketoacidosis, uncontrolled diabetes, high vitamin D levels, and low parathyroid hormone levels. Hyperphosphatemia Drugs Market Drivers Increasing launches and a